What happens after our C-MIC device is switched off? Read our new manuscript on the results of the C-MIC II follow-up study! academic.oup.com/eurjhf/adva…
The last enrollment in C-MIC III Less Invasive Study completed! We look forward to sharing results with you. We are grateful to all patients, their caregivers and our Clinical Investigation Teams for participating in this important step!
Two late-breaking presentations at HFSA 2026 highlighted new findings on cardiac microcurrent therapy.
Thank you to our investigators, study teams, and participating patients!
C-MIC is an investigational device and is not approved for commercial use.
Exciting times ahead at the conference HFSA in Phoenix Arizona! Our team will present 2 late breaking clinic research studies and participate in Trial Tender. Stay tuned!
Our latest article, published in Circulation: Heart Failure, reviews the emerging clinical evidence and explores the potential biological mechanisms underlying cardiac microcurrent therapy. 👉 ahajournals.org/doi/epub/10.… Thanks to all the authors!
Berlin Heals Holding AG receives further financing for revolutionary heart implant!
prnewswire.com/news-releases…
Ostern ist das Fest der Hoffnung. Hoffnung auf ein neues Leben. Wir wünschen allen Menschen zu Ostern neue Hoffnung und neue Kraft für ein besseres Morgen.
Today we celebrate hope. Hope for a new life. We wish for all people a Happy Easter with new hope and new power for a better tomorrow.
Wünsche die von Herzen kommen: Ein frohes Weihnachtsfest und einen guten Start in ein gesundes neues Jahr. 💝🎄🎉
Thanks @scirent
for your expertise and brilliant work. nitter.cf/scirent/status/1400345…
Replying to @BerlinHeals
@BerlinHeals innovative implantable C-MIC device delivers encouraging clinical results in the treatment of heart failure. SCIRENT conducted the first-in-human pilot study for this device. We are proud to support Berlin Heals in this trial.
Learn more: bit.ly/3fHsQmY
We are very proud about that.
BERLIN HEALS Receives Breakthrough Device Designation from FDA for its C-MIC Heart Failure Device and Initiates Early Feasibility Study in the United States Johannes Mueller, MD @BerlinHeals
#HeartFailure #Cardiology #Heart #research
cardiologytalk.com/video/372…...
Results of our first-in-human study in short: Patients’ mean 6-minute walking distance almost doubled in 14 days and all of the patients' hearts, which were typically enlarged, had shrunk. All patients saw NYHA classification drop by two classes.
#HeartFailure #Cardiology
Our device has the potential for healing heart failure rather than just delaying the progression of the disease. Thanks for trusting us. #FDA #BerlinHeals #CMIC #heartfailure #microcurrent #electroceuticals
cardiovascularbusiness.com/t…
Unsere First-in-human Studie ist abgeschlossen und die Ergebnisse sind wirklich beeindruckend: berlinheals.com/en/notes/car…
Berlin Heals has developed a completely new type of implantable medical device with the goal of treating heart failure with electrical micro current. The aim is to achieve true myocardial recovery.
#CMIC #heart #microcurrent
Berlin Heals hat ein völlig neuartiges implantierbares Medical Device entwickelt, mit dem Ziel, Herzinsuffizienz mit elektrischem Mikrostrom zu behandeln. Damit soll eine eine echte myokardiale Erholung erreicht werden. #CMIC #Herz #Mikrostrom













